Real-time enrollment status for this locally advanced clear cell renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:44 PM UTC
| NCT Number | NCT06866262 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Clear Cell Renal Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 55 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | September 9, 2025 (Sep 9, 2025) |
As of July 17, 2026: Clinical trial NCT06866262 is currently recruiting participants. This phase1 study for locally advanced clear cell renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06866262 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06866262 was last updated Sep 9, 2025 (September 9, 2025). HelloStudys verifies this status automatically.